
Reset all filters
01 2AbbVie Corporation
Reset all filters
01 22514507
Reset all filters
01 2LINACLOTIDE
Reset all filters
01 2CAPSULE
Reset all filters
01 22024-01-28
Patent Expiration Date : 2024-01-28
Date Granted : 2012-03-20
Brand Name : CONSTELLA
Patent Number : 2514507
Filing Date : 2004-01-28
Strength per Unit : 145 ?g
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-01-28
Date Granted : 2012-03-20
Patent Expiration Date : 2024-01-28
Date Granted : 2012-03-20
Brand Name : CONSTELLA
Patent Number : 2514507
Filing Date : 2004-01-28
Strength per Unit : 290 ug
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-01-28
Date Granted : 2012-03-20